Chao-Peng Shao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Chao-Peng Shao has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Chang-Lin Wu
Shenzhen Univ, Shenzhen Peoples Hosp 2, Dept Blood Transfus, Affiliated Hosp 1, Shenzhen, Peoples R China
6 shared publicationsHua Xu
Shanxi Blood Center, Xi'an, Shanxi, China
3 shared publicationsPin Yi
Shenzhen Univ, Shenzhen Peoples Hosp 2, Dept Blood Transfus, Affiliated Hosp 1, Shenzhen, Peoples R China
3 shared publicationsWen Xiong
3 shared publicationsXue-Dong Wang
Center for Precision Medicine, Anhui No. 2 Provincial People's Hospital, Hefei, Anhui 230041, China; Department of Clinical Laboratory Medicine, The Fifth People's Hospital of Wuxi, Nanjing Medical University, Wuxi, Jiangsu, 214000, China
3 shared publicationsChanglin Wu
Guangdong Medical University, Zhanjiang 524023, China
2 shared publications
Latest Publications
- 1 June 2025
- Vol. 41 (6) , 559-563
[Recent progress in the regulation of cellular immunity to erythrocyte homologous immunity].
Chronic anemia patients (such as thalassemia) often rely on long-term red blood cell transfusion to sustain life. However, alloimmune reactions against blood group antigens can pose serious risks to the patients' clinical treatment and survival. The regulatory mechanisms of transfusion-related alloimmunity are not yet well understood. For example, some patients, despite long-term transfusions, do not develop alloimmune reactions, while others produce alloantibodies against multiple blood group antigens, making transfusion therapy increasingly difficult. Red blood cell blood group alloimmunity involves various immune cells, including antigen-presenting cells and different T cells. Many studies are exploring the regulatory roles and even potential interventions. This article reviews the correlation between cellular immunity and red blood cell blood group antigens in alloimmune responses, and explores the interaction between the two, as well as their impact on immune responses.
- 1 June 2025
- Vol. 41 (6) , 559-563
[Recent progress in the regulation of cellular immunity to erythrocyte homologous immunity].
Chronic anemia patients (such as thalassemia) often rely on long-term red blood cell transfusion to sustain life. However, alloimmune reactions against blood group antigens can pose serious risks to the patients' clinical treatment and survival. The regulatory mechanisms of transfusion-related alloimmunity are not yet well understood. For example, some patients, despite long-term transfusions, do not develop alloimmune reactions, while others produce alloantibodies against multiple blood group antigens, making transfusion therapy increasingly difficult. Red blood cell blood group alloimmunity involves various immune cells, including antigen-presenting cells and different T cells. Many studies are exploring the regulatory roles and even potential interventions. This article reviews the correlation between cellular immunity and red blood cell blood group antigens in alloimmune responses, and explores the interaction between the two, as well as their impact on immune responses.
- 1 January 2024
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 70 (03/2024) , 614-617
Molecular and Family Analyses of a Novel RHD1058G>C Allele in a Chinese RhD Population
Background: Rh(D) phenotype in a sample from a 19-year-old female patient showed weak positivity (1+). A follow-up sample was requested to further define the Rh(D) phenotype, her Rh(D) phenotype was tested by using another reagent, Rh(D) phenotype still showed weak reactivity (1+), RhCcEe phenotype was Ccee. Methods: Seven samples from the family members of the proposita were received. The RhDCcEe phenotypes were typed by the micro-column gel card and the unexpected antibodies were assayed by indirect anti- human globulin test (IAT). Genomic DNA was extracted from the blood sample and the novel RHD1058G>C allele was detected through an established sequence-specific primer PCR (PCR-SSP), RHD exons 1 - 10 were sequenced afterward by exon-specific amplification. The distribution of RHD1058G>C allele and RHD weak positive phenotype were investigated in the pedigrees. Results: The unexpected antibodies all were negative in the family members. The novel RHD1058G>C allele was found in the proposita, her father, and grandfather. Five family members were detected serologically with the common Rh(D)-positive phenotypes either as homozygote of RHD/RHD or heterozygote of RHD/RHd. Two family members were detected as weak D phenotypes in accordance with the genotyping results by PCR-SSP, and both of them have a (DCe)-Ce-1058 haplotype and a dce haplotype. One member, her father, was tested common Rh( D)-positive with (DCe)-Ce-1058 haplotype and a Dce haplotype. Conclusions: These data allow us to describe the characteristics of the weak D phenotype with a novel c. RHD1058G>C allele, which may be partial D and increase the risk of RHD alloantibody. The novel RHD1058G>C allele was inherited in three generations in a family rather than spontaneous mutation in an individual.
- 1 January 2024
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 70 (03/2024) , 614-617
Molecular and Family Analyses of a Novel RHD1058G>C Allele in a Chinese RhD Population
Background: Rh(D) phenotype in a sample from a 19-year-old female patient showed weak positivity (1+). A follow-up sample was requested to further define the Rh(D) phenotype, her Rh(D) phenotype was tested by using another reagent, Rh(D) phenotype still showed weak reactivity (1+), RhCcEe phenotype was Ccee. Methods: Seven samples from the family members of the proposita were received. The RhDCcEe phenotypes were typed by the micro-column gel card and the unexpected antibodies were assayed by indirect anti- human globulin test (IAT). Genomic DNA was extracted from the blood sample and the novel RHD1058G>C allele was detected through an established sequence-specific primer PCR (PCR-SSP), RHD exons 1 - 10 were sequenced afterward by exon-specific amplification. The distribution of RHD1058G>C allele and RHD weak positive phenotype were investigated in the pedigrees. Results: The unexpected antibodies all were negative in the family members. The novel RHD1058G>C allele was found in the proposita, her father, and grandfather. Five family members were detected serologically with the common Rh(D)-positive phenotypes either as homozygote of RHD/RHD or heterozygote of RHD/RHd. Two family members were detected as weak D phenotypes in accordance with the genotyping results by PCR-SSP, and both of them have a (DCe)-Ce-1058 haplotype and a dce haplotype. One member, her father, was tested common Rh( D)-positive with (DCe)-Ce-1058 haplotype and a Dce haplotype. Conclusions: These data allow us to describe the characteristics of the weak D phenotype with a novel c. RHD1058G>C allele, which may be partial D and increase the risk of RHD alloantibody. The novel RHD1058G>C allele was inherited in three generations in a family rather than spontaneous mutation in an individual.
- 1 January 2023
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 69 (10/2023) , 2156-2159
A Novel RHCE*cE (c.827C>A) Allele, Containing the Single-Nucleotide Change, Encodes Altered c/E Antigens
The RH blood group system is the most complex with over 50 antigens. So far over hundreds of RhCE variant alleles have been described resulting in weakened and/or partial expression of RhCE antigens [1], some variant Rh phenotypes are caused by exchange of genetic material between the RHD and RHCE genes, resulting in many hybrid genes, other phenotypes result from missense mutations. Variant alleles encode altered phenotypes with either weakened antigens, lacked antigens, or unexpected antigens. Besides, the mutation of RH blood group genes may lead to the changes of Rh antigen epitopes. RHCE gene mutations or polymorphisms may bring about altered RH antigens in quality and quantity [2]. Serologic weaknesses or discrepancies are regularly faced by blood transfusion laboratories, and molecular background explaining this feature can be precisely characterized only by the molecular biological methods.
- 1 January 2023
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 69 (10/2023) , 2156-2159
A Novel RHCE*cE (c.827C>A) Allele, Containing the Single-Nucleotide Change, Encodes Altered c/E Antigens
The RH blood group system is the most complex with over 50 antigens. So far over hundreds of RhCE variant alleles have been described resulting in weakened and/or partial expression of RhCE antigens [1], some variant Rh phenotypes are caused by exchange of genetic material between the RHD and RHCE genes, resulting in many hybrid genes, other phenotypes result from missense mutations. Variant alleles encode altered phenotypes with either weakened antigens, lacked antigens, or unexpected antigens. Besides, the mutation of RH blood group genes may lead to the changes of Rh antigen epitopes. RHCE gene mutations or polymorphisms may bring about altered RH antigens in quality and quantity [2]. Serologic weaknesses or discrepancies are regularly faced by blood transfusion laboratories, and molecular background explaining this feature can be precisely characterized only by the molecular biological methods.
- 1 January 2022
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 68 (04/2022) , 864-868
Alloantibodies, Specificities, and Alloimmunization Outcomes through Rh Extended Matching Transfusion for Thalassemia Patients
- 1 January 2022
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 68 (04/2022) , 864-868
Alloantibodies, Specificities, and Alloimmunization Outcomes through Rh Extended Matching Transfusion for Thalassemia Patients
- 17 October 2021
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 61 (1) , 103295
A novel RHCE*cE allele identified in a Chinese individual, encodes weakened expression of c and E antigens
- 17 October 2021
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 61 (1) , 103295
A novel RHCE*cE allele identified in a Chinese individual, encodes weakened expression of c and E antigens
- 22 July 2021
- Published by Wiley in Transfusion
- Vol. 61 (9) , E55-E56
A new RHD variant allele caused by an RHDc.1228‐1G>C mutation in a Chinese family
- 22 July 2021
- Published by Wiley in Transfusion
- Vol. 61 (9) , E55-E56
A new RHD variant allele caused by an RHDc.1228‐1G>C mutation in a Chinese family
- 1 February 2021
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 60 (1) , 102912
Family investigation of a DEL with RHD838A allele
- 1 February 2021
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 60 (1) , 102912
Family investigation of a DEL with RHD838A allele
- 1 January 2021
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 67 (09/2021) , 2164-2167
A Rare DEL with RHD93T>A Allele from Family Investigation
- 1 January 2021
- Published by Clinical Laboratory Publications in Clinical Laboratory
- Vol. 67 (09/2021) , 2164-2167
A Rare DEL with RHD93T>A Allele from Family Investigation
Identification of a novel HLA‐A*11 allele, HLA‐A*11:333, in a Chinese individual
A*11:333 differs from A*11:01:01 by one nucleotide change at nucleotide 865 in exon 4 from G to A.
Identification of a novel HLA‐A*11 allele, HLA‐A*11:333, in a Chinese individual
A*11:333 differs from A*11:01:01 by one nucleotide change at nucleotide 865 in exon 4 from G to A.
- Open Access
- 5 July 2018
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 45 (4) , 252-257
Rh-Matched Transfusion through Molecular Typing for β-Thalassemia Patients Is Required and Feasible in Chinese
Background: Molecular typing for RHCE blood group alleles has been established in many countries for patients and blood donors. In the Chinese literature nearly 80% of transfused patients with alloimmunization have antibodies specific for antigens of the Rh blood group system. We investigated if it is feasible to match packed red blood cells (RBCs) for Chinese β-thalassemia patients by RHCE genotyping. Methods: In this study, 481 patients with β-thalassemia were enrolled. They were genotyped for RHCE alleles by a simple PCR method with sequence-specific primers (PCR-SSP). Among these patients, 203 continuously received RBCs of the identical Rh subgroups according to the genotyping results for at least 3 months. Subsequently, their phenotypes were tested through a micro-column gel card method. For validation purposes, 400 donors were serologically typed with the same technology, of which 164 were genotyped too. Finally, the C, c, E, and e frequencies and the feasibility of the simple genotyping method were analyzed. Results: All patients showed mixed-field agglutination in the Rh subgroup gel cards before the same Rh subgroups in blood donors were selected for blood transfusion. The results, however, lacked mixed-field agglutination in all 203 cases after transfusion with RBC concentrates selected for the patient's C, c, E, and e antigens for at least 3 months. The genotyping results of 164 donors were all consistent with the serological results. Whole coding regions of RHCE were sequenced in 7 individuals with weak c, E, or e antigens. In only one sample we observed a 1059G>A nucleotide mutation coding for a truncated RhCE polypeptide (GenBank KT957625), in the other 6 samples no sequence variant was found. Both patients and donors were predominantly CcEe and CCee, with a prevalence of 55.3% and 24.9% for patients or 49.3% and 31.3% for donors, respectively. It revealed that about 80% of Chinese could receive Rh-matched RBCs easily. Conclusion: A simple RHCE genotyping technique is safe enough for Rh-matched transfusion of β-thalassemia patients in Chinese Han.
- 5 July 2018
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 45 (4) , 252-257
Open AccessRh-Matched Transfusion through Molecular Typing for β-Thalassemia Patients Is Required and Feasible in Chinese
Background: Molecular typing for RHCE blood group alleles has been established in many countries for patients and blood donors. In the Chinese literature nearly 80% of transfused patients with alloimmunization have antibodies specific for antigens of the Rh blood group system. We investigated if it is feasible to match packed red blood cells (RBCs) for Chinese β-thalassemia patients by RHCE genotyping. Methods: In this study, 481 patients with β-thalassemia were enrolled. They were genotyped for RHCE alleles by a simple PCR method with sequence-specific primers (PCR-SSP). Among these patients, 203 continuously received RBCs of the identical Rh subgroups according to the genotyping results for at least 3 months. Subsequently, their phenotypes were tested through a micro-column gel card method. For validation purposes, 400 donors were serologically typed with the same technology, of which 164 were genotyped too. Finally, the C, c, E, and e frequencies and the feasibility of the simple genotyping method were analyzed. Results: All patients showed mixed-field agglutination in the Rh subgroup gel cards before the same Rh subgroups in blood donors were selected for blood transfusion. The results, however, lacked mixed-field agglutination in all 203 cases after transfusion with RBC concentrates selected for the patient's C, c, E, and e antigens for at least 3 months. The genotyping results of 164 donors were all consistent with the serological results. Whole coding regions of RHCE were sequenced in 7 individuals with weak c, E, or e antigens. In only one sample we observed a 1059G>A nucleotide mutation coding for a truncated RhCE polypeptide (GenBank KT957625), in the other 6 samples no sequence variant was found. Both patients and donors were predominantly CcEe and CCee, with a prevalence of 55.3% and 24.9% for patients or 49.3% and 31.3% for donors, respectively. It revealed that about 80% of Chinese could receive Rh-matched RBCs easily. Conclusion: A simple RHCE genotyping technique is safe enough for Rh-matched transfusion of β-thalassemia patients in Chinese Han.